ASTRO members receive fellows designation
The American Society for Radiation Oncology selected 17 members to receive the ASTRO fellows designation.
The designees will be recognized during a ceremony at ASTRO’s 57th annual meeting, scheduled for Oct. 18-21 in San Antonio.
ASTRO fellows designation honors individuals who have been an active or emeritus member of ASTRO for at least 15 years, given the equivalent of 10 years of service to ASTRO, and significantly added to the field of radiation oncology in the areas of research, education, patient care or service and leadership.
ASTRO has recognized 259 fellows since 2006.
“The 17 fellows chosen this year have demonstrated their dedication to the field of radiation oncology. Their work has impacted and benefited patients and the field of radiation oncology in a variety of ways, including patient care, research, education, service and leadership,” Bruce G. Haffty, MD, FASTRO, chair of ASTRO’s board of directors, said in a press release. “I congratulate this talented group of colleagues selected for the ASTRO Fellows designation.”
Members of the 2015 fellows class are May Abdel-Wahab, MD, PhD, of International Atomic Energy Agency in Vienna, Austria; Kaled M. Alektiar, MD, of Memorial Sloan Kettering Cancer Center; Manjeet Chadha, MD, of Mount Sinai Beth Israel; A. Bapsi Chakravarthy, MD, of Vanderbilt University; Eric L. Chang, MD, of Keck School of Medicine of University of Southern California, Los Angeles; Joel M. Cherlow, MD, PhD, of Long Beach Radiation Oncology Medical Group and Orange County CyberKnife and Radiation Oncology Center; Martin Colman, MD, of University of Texas Medical Branch Galveston; Carol A. Hahn, MD, of Duke Cancer Institute; James M. Larner, MD, of University of Virginia; Robert C. Miller, MD, MBA, of Mayo Clinic in Jacksonville, Florida; Arnold dela Cruz Paulino, MD, of The University of Texas MD Anderson Cancer Center; Rachel Rabinovitch, MD, of University of Colorado School of Medicine; C. Leland Rogers, MD, of Virginia Commonwealth University; David I. Rosenthal, MD, of The University of Texas MD Anderson Cancer Center; Richard Kenneth Valicenti, MD, MA, of University of California, Davis; Julia White, MD, of The Ohio State University Comprehensive Cancer Center; and Yan Yu, PhD, MBA, of Thomas Jefferson University.